VANGUARD partners have published a publication titled The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time as part of the Transplant International special
As part of the Transplant International special issue on The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering, VANGUARD partners published a review article on Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and
On the 3rd and 4th of July, the cosmopolitan city of Milan, Italy, played host to the bi-annual project meeting of VANGUARD. The meeting was organised by Lorenzo Piemonti and his team from San Raffaele Hospital. The agenda was dense
A new VANGUARD article on Therapeutic potential of fetal liver cell transplantation in hemophilia A mice has recently been published in haematologica. The publication is available open access online: https://haematologica.org/article/view/haematol.2022.282001 Abstract Hemophilia A (HA) cell therapy approaches in pediatric individuals
Team members of the VANGUARD project travelled to Igls in Austria for the annual consortium meeting which was held on 22 January 2023. The full day meeting covered the research progress of all work packages in the first three years
During the annual VANGUARD project meeting 2022 held in Geneva, Switzerland we spoke to all project partners involved about the objectives of VANGUARD, their role within the project and the possible impact generating a vascularized and immune-protected bioartificial pancreas that
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700